Green Cross Medical Science Balance Sheet Health
Financial Health criteria checks 4/6
Green Cross Medical Science has a total shareholder equity of ₩36.9B and total debt of ₩15.7B, which brings its debt-to-equity ratio to 42.5%. Its total assets and total liabilities are ₩90.5B and ₩53.6B respectively. Green Cross Medical Science's EBIT is ₩1.3B making its interest coverage ratio 0.4. It has cash and short-term investments of ₩5.7B.
Key information
42.5%
Debt to equity ratio
₩15.71b
Debt
Interest coverage ratio | 0.4x |
Cash | ₩5.74b |
Equity | ₩36.92b |
Total liabilities | ₩53.61b |
Total assets | ₩90.53b |
Recent financial health updates
Recent updates
We Think Green Cross Medical Science's (KOSDAQ:142280) Solid Earnings Are Understated
Mar 26Investors Shouldn't Be Too Comfortable With Green Cross Medical Science's (KOSDAQ:142280) Robust Earnings
Mar 23These 4 Measures Indicate That Green Cross Medical Science (KOSDAQ:142280) Is Using Debt Extensively
Feb 24Is Green Cross Medical Science's (KOSDAQ:142280) Share Price Gain Of 128% Well Earned?
Jan 28Is Green Cross Medical Science Corporation (KOSDAQ:142280) Popular Amongst Insiders?
Jan 02Should We Be Excited About The Trends Of Returns At Green Cross Medical Science (KOSDAQ:142280)?
Dec 07Financial Position Analysis
Short Term Liabilities: A142280's short term assets (₩43.3B) do not cover its short term liabilities (₩46.5B).
Long Term Liabilities: A142280's short term assets (₩43.3B) exceed its long term liabilities (₩7.1B).
Debt to Equity History and Analysis
Debt Level: A142280's net debt to equity ratio (27%) is considered satisfactory.
Reducing Debt: A142280's debt to equity ratio has reduced from 148.8% to 42.5% over the past 5 years.
Debt Coverage: A142280's debt is well covered by operating cash flow (27%).
Interest Coverage: A142280's interest payments on its debt are not well covered by EBIT (0.4x coverage).